SCHEMBL107996

SCHEMBL107996

CCC(C)C=CC(C)CC

nearest known ligand 0.38

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.38
GAPDH P04406 1/20 0.35
TRPA1 O75762 1/20 0.32
TRPV1 Q8NER1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL107995 1.00 TSHR (0.38) TSHRGAPDHTRPA1TRPV1
SCHEMBL108107 0.89
SCHEMBL108108 0.89
SCHEMBL8960708 0.84
SCHEMBL8960712 0.84
SCHEMBL111006 0.82
SCHEMBL11421439 0.82
SCHEMBL111007 0.82
SCHEMBL16492659 0.82
SCHEMBL1760665 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2463374-A2 Isolated alcohol dehydrogenase enzymes and uses thereof Bio Architecture Lab, Inc. (US) 2012-06-13 EP claimed
EP-2195440-A2 BIOFUEL PRODUCTION Bio Architecture Lab, Inc. (US) 2010-06-16 EP claimed
US-20090155873-A1 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-06-18 US claimed
US-20090139134-A1 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-06-04 US claimed
WO-2009046375-A2 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-04-09 WO claimed
WO-2009046370-A2 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-04-09 WO claimed
EP-3230463-B2 RAPID PRETREATMENT APALTA PATENTS OUE (EE) 2025-07-16 EP disclosed
US-20240425893-A1 RAPID PRETREATMENT Apalta Patents OÜ (EE) 2024-12-26 US disclosed
US-12054761-B2 Rapid pretreatment Apalta Patents OÜ (EE) 2024-08-06 US disclosed
US-11821047-B2 High pressure zone formation for pretreatment Apalta Patent OÜ (EE) 2023-11-21 US disclosed
US-20230295678-A1 RAPID PRETREATMENT Apalta Patents OÜ (EE) 2023-09-21 US disclosed
EP-4098750-A1 RAPID PRETREATMENT Sweetwater Energy, Inc. (US) 2022-12-07 EP disclosed
EP-3230463-B1 RAPID PRETREATMENT SWEETWATER ENERGY INC (US) 2022-05-25 EP disclosed
EP-1659108-B1 Two-step process to produce methyl branched organic compounds using dimethyl ether and hydrogen AIR PROD & CHEM (US) 2008-07-16 EP disclosed
CN-1914245-A Thermoplastic elastomer composition and molded article KANEGAFUCHI CHEMICAL IND (JP) 2007-02-14 CN disclosed
US-20060111589-A1 Two-step process to produce methyl branched organic compounds using dimethyl ether and hydrogen AIR PRODUCTS AND CHEMICALS, INC. 2006-05-25 US disclosed
EP-1659108-A1 Two-step process to produce methyl branched organic compounds using dimethyl ether and hydrogen Air Products and Chemicals, Inc. (US) 2006-05-24 EP disclosed
US-6872493-B2 Nonaqueous electrolytic solution and nonaqueous secondary battery DENSO CORPORATION (JP) 2005-03-29 US disclosed
US-20020076619-A1 Nonaqueous electrolytic solution and nonaqueous secondary battery ADEKA CORPORATION (JP) 2002-06-20 US disclosed
EP-1202373-A2 Nonaqueous electrolytic solution and nonaqueous secondary battery DENSO CORPORATION (JP) 2002-05-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060111589-A1 Two-step process to produce methyl branched organic compounds using dimethyl ether and hydrogen MCCC2, MSMO1, ALKBH3 TSHR 4720/4885GAPDH 467/4885TRPA1 3914/4885
US-20090139134-A1 BIOFUEL PRODUCTION MGAM, DCXR, MANBA TSHR 3426/4885GAPDH 493/4885TRPA1 3765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.